ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Abstract Number: 1965
    T Cell Activation, Proliferation and Differentiation Markers Lack Diagnostic Accuracy for Detecting Active GCA and PMR
  • Abstract Number: 3216
    T Cell Restricted Deletion of Serine/Arginine-Rich Splicing Factor 1 (SRSF1) in Mice Causes Immune Cell Dysfunction and Contributes to Lupus-like Nephritis
  • Abstract Number: 2040
    T Follicular Helper like CD4+CXCR5+pd-1+ Cells and T Follicular Helper like Type 2 Cells Subsets Are Increased in IgG4-Related Disease Patients
  • Abstract Number: 1383
    T-Cell Subset Analysis in IgG4-Related Disease and Lymphocyte-Variant Hypereosinophilic Syndrome
  • Abstract Number: 2224
    Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions
  • Abstract Number: 3071
    Takayasu’s Arteritis and Pregnancy
  • Abstract Number: 3054
    Takayasu’s Arteritis Associated with Behçet’s Syndrome: A Case Series of 8 Patients
  • Abstract Number: 2204
    Tankyrase Regulates Osteoclastogenesis Via SH3BP2 Expression
  • Abstract Number: 2454
    Target and Targetoid Reactions at Bacillus Calmettee-Guérin Inoculation Site Revealed By Dermatoscopy Correlate with Systemic Involvements in Patients with Kawasaki Disease
  • Abstract Number: 1828
    Target Modulation of a Type I Interferon Gene Signature and Pharmacokinetics of Anifrolumab in a Phase IIb Study of Patients with Moderate to Severe Systemic Lupus Erythematosus
  • Abstract Number: 219
    Targeted Deep Resequencing Identifies MRP4/ABCC4 as a Gout Risk Locus in the New Zealand Mä�ori and Pacific Island Populations
  • Abstract Number: 521
    Targeted Quantitative Analysis to Identify Citrullinated Peptides in the Synovial Fluid of Patients with Rheumatoid Arthritis
  • Abstract Number: 2677
    Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis
  • Abstract Number: 2015
    Targeting Non-Canonical NF-Kappa B Signaling Inhibits Angiogenesis in a Novel 3D Model of Rheumatoid Arthritis Synovial Angiogenesis
  • Abstract Number: 2546
    Targeting Synovial Fibroblasts By the Intra-Articular Delivery of microRNA-140-3p and -5p Ameliorates Experimental Autoimmune Arthritis
  • Abstract Number: 2561
    TAS5315, a Novel Bruton’s Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
  • Abstract Number: 535
    Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis
  • Abstract Number: 2080
    Teaching Fellows in Lupus: Rheumatology Fellows Are Successful Educators in Improving Lupus Recognition By Frontline Healthcare Providers
  • Abstract Number: 2222
    Teaching Rheumatology in Undergraduate Medical Education: What Are the Students Saying?
  • Abstract Number: 2230
    Teaching the Teachers: Report of an Effective Mixed-Method Course Training Clinical Educators to Provide Instruction in Musculoskeletal Care to Other Providers and Learners in Primary Care
  • Abstract Number: 2495
    Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis
  • Abstract Number: 2496
    Telerheumatology: A Technology Not Appropriate for All
  • Abstract Number: 1606
    Telomere Damage in Rheumatoid Arthritis
  • Abstract Number: 1593
    Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis
  • Abstract Number: 1534
    Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations
  • Abstract Number: 1066
    Temporal Trends and Outcomes of Acute Myocardial Infarction in Systemic Lupus Erythematosus Hospitalizations
  • Abstract Number: 2103
    Temporal Trends in Drug Prescription, Utilization and Costs Among Rheumatoid Arthritis (RA) Patients Show Wide Regional Variation Despite Universal Drug Coverage
  • Abstract Number: 1482
    Temporomandibular Pain in Patients with Juvenile Idiopathic Arthritis
  • Abstract Number: 2649
    Test-Retest Reliability of the 5-Item Compliance Questionnaire Rheumatology and Factors Influencing Its Assessment of Adherence in Patients with Rheumatoid Arthritis
  • Abstract Number: 1147
    TGFß1 Blocks Chondrocyte Hypertrophy and Increases Cell Viability in Cultured Cartilage Explants but Does Not Protect Against Proteoglycan Loss
  • Abstract Number: 2695
    Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1156
    Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
  • Abstract Number: 994
    Th17/Tfh Cell Predict Disease Severity in Rheumatoid Arthritis Patients Receiving TNF Inhibitor Therapy
  • Abstract Number: 2608
    The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission
  • Abstract Number: 305
    The “Sleeve Sign”� in Dermatomyositis
  • Abstract Number: 2406
    The 2011 Fibromyalgia (FM) Criteria Are Helpful in Identifying Central Sensitization in Knee Osteoarthritis
  • Abstract Number: 2290
    The 2011 Fibromyalgia (FM) Survey Criteria Are a Surrogate Measure of Pain Centralization
  • Abstract Number: 2857
    The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries
  • Abstract Number: 96
    The ABCG2 polymorphism Is Associated with Hyperuricemia in a Community-Based Korean Cohort
  • Abstract Number: 2176
    The Ability of Recombinant Domain I of Beta-2-Glycoprotein I to Inhibit Lupus Anticoagulant Effect of IgG from Patients with APS Is Enhanced By Pegylation
  • Abstract Number: 2396
    The Absence of Symptom in Subjects with Advanced Knee OA
  • Abstract Number: 1149
    The Active Metabolite of Fostamatinib, R406, Only Decreases the Inflammation-Driven Extracellular Matrix Turnover of the Joint at High Concentrations Ex Vivo
  • Abstract Number: 3021
    The Adaptor Protein Crkii Regulates Rap1 Activation in the Immunological Synapse
  • Abstract Number: 956
    The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Other Adverse Events
  • Abstract Number: 1170
    The Alarmins S100A8/A9 Induce Canonical Wnt Signaling in Naïve Joints and Experimental OA
  • Abstract Number: 873
    The ANCA-Vasculitis Index of Damage (AVID): Performance of a New Damage Instrument
  • Abstract Number: 3133
    The Anti-Fibrotic Effect of Endostatin-Derived Peptide Is Mediated By the Urokinase Pathway Via Binding to Enolase-1 and Urokinase Plasminogen Activator Receptor
  • Abstract Number: 2366
    The Anti-MDA5 Autoantibody Phenotype: Defining Clinical, Biochemical and Radiological Features Suggestive of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease
  • Abstract Number: 3060
    The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center
  • Abstract Number: 3036
    The Association Between Behcet’s Disease, Myelodysplastic Syndrome and Trisomy 8
  • Abstract Number: 1510
    The Association Between HDL Cholesterol Efflux Capacity, Citrullinated ApoA1 and Anti-Citrullinated ApoA1 Antibodies in Rheumatoid Arthritis
  • Abstract Number: 2479
    The Association Between Social Networks, Disease Activity, and Pain in Rheumatoid Arthritis
  • Abstract Number: 1626
    The Association of HLA-DRB1 Alleles and Amino Acid Residues with Radiographic Severity in African Americans with Seropositive Rheumatoid Arthritis
  • Abstract Number: 2276
    The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study
  • Abstract Number: 173
    The Automated Software-Guided Ultrasound Assessment of Bilateral Common Carotids Intima-Media Thickness for Investigation of Cardiovascular Risk in Psoriasis:Comparison Between Patients with or without Arthritis
  • Abstract Number: 1117
    The B Cell Survival Cytokine BAFF Promotes Systemic Lupus Erythematosus Via Activation of TACI, Not BAFF Receptor
  • Abstract Number: 1648
    The Balance of Foxp3/Ror-Gammat Expression Is Altered By Tocilizumab and By Abatacept in Patients with Rheumatoid Arthritis
  • Abstract Number: 2275
    The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups
  • Abstract Number: 1283
    The Burden of Non-Radiographic Axial Spondyloarthritis from the Employer Perspective: A Real World European Study
  • Abstract Number: 3019
    The CD4+CD52low T Cell Contributes to Disease Activity and Autoantybody Production in Systemic Lupus Erythematosus
  • Abstract Number: 1531
    The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years
  • Abstract Number: 1199
    The Charla De Lupus (Lupus Chat)® Program: An Evaluation of a Lupus Support Program for Teens, Young Adults and Parents
  • Abstract Number: 3183
    The Clinical and Economic Costs of Not Achieving Remission in Rheumatoid Arthritis
  • Abstract Number: 355
    The Clinical and Genetic Spectrum of Low Alkaline Phosphatase in Adults
  • Abstract Number: 1216
    The Clinical and Ultrasonographic Presentation of Seronegative RA Is More Severe Compared to Seropositive RA in an Inception Cohort of DMARD-Naïve Patients Classified According to the 2010 ACR/EULAR Criteria
  • Abstract Number: 3203
    The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, in Primary Sjögren’s Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial
  • Abstract Number: 2371
    The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti- Melanoma Differentiation-Associated Gene 5 Antibody
  • Abstract Number: 1535
    The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
  • Abstract Number: 2384
    The Comparative Efficacy of Dry Needling, Kinesio Taping and Physical Therapy in Patients with Myofascial Pain Syndrome
  • Abstract Number: 3232
    The Comparative Efficacy of Kinesio Taping and Local Steroid Injection in Patients with Subacromial Impingement Syndrome
  • Abstract Number: 2328
    The Correlation of Childhood Health Assessment Questionnaire with Disease Activity in Juvenile Idiopathic Arthritis
  • Abstract Number: 1183
    The Country Where You Perform Your Rheumatology Training Is Associated with the Acquired Confidence, the Education Received and the Assessment in Core Competences
  • Abstract Number: 537
    The Course of Bone Marrow Edema in Early Undifferentiated and Rheumatoid Arthritis; A Longitudinal MRI Study on Bone Level
  • Abstract Number: 28
    The Decrease over Time of Orthopaedic Surgery in Patients with Rheumatoid Arthritis Is Mainly Due to Reduced Rates Among Those with Rheumatoid Factor Positive Disease – Results from a Well Defined Area
  • Abstract Number: 2732
    The Effect of Adrenocorticotropin Gel (HP Acthar Gel) in Combination with MTX in Newly Diagnosed RA Patients from a Clinical and Structural Perspective
  • Abstract Number: 1560
    The Effect of Anti Estrogen Therapy (AET) on Rheumatoid Arthritis
  • Abstract Number: 1426
    The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice
  • Abstract Number: 2387
    The Effect of Arthroscopic Partial Meniscectomy in Patients with Osteoarthritis on Meniscal Body Extrusion
  • Abstract Number: 729
    The Effect of Belimumab on Peripheral Blood Cells in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2599
    The Effect of Daily Low Dose Prednisone (divided daily versus single daily dose) in the Treatment of African Americans (AA) with Early Rheumatoid Arthritis (RA)
  • Abstract Number: 342
    The Effect of Erosive Status on Systemic Inflammatory Biomarkers in Hand Osteoarthritis
  • Abstract Number: 1429
    The Effect of Gabapentin and Cyclooxygenase Inhibitors on Evoked and Ongoing Pain-like Behavior in Two Arthritis Models in Mice
  • Abstract Number: 1449
    The Effect of IL-1 Receptor Antagonist Anakinra (Kineret®) on Measures of Central Nervous System Inflammation and Headaches in Pediatric Patients with Severe Cryopyrin-Associated Periodic Syndromes
  • Abstract Number: 2575
    The Effect of mPGES-1 Deletion on Platelet Function in Mice
  • Abstract Number: 2726
    The Effect of Prior Disease Duration and Prior DMARD Use on Treatment Outcomes in Patients with Early or Established Rheumatoid Arthritis
  • Abstract Number: 459
    The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry
  • Abstract Number: 2147
    The Effect of Sulfasalazine and Methotrexate on the Immunogenicity of Infliximab and Adalimumab in Patients with Spondyloarthritis
  • Abstract Number: 116
    The Effect of the Formal Approval of Colchicine on Utilization of Emergency Department and Rheumatology Outpatient Services By Patients with Gout
  • Abstract Number: 1561
    The Effect of TNF Blockers on Bone Mineral Density in Rheumatoid Arthritis Patients Receiving Bisphosphonate
  • Abstract Number: 975
    The Effect of TNF Inhibition on Radiographic Progression in Ankylosing Spondylitis: An Observational Cohort Study of 374 Patients
  • Abstract Number: 973
    The Effect of TNF Inhibitor Treatment on Occurrence of Anterior Uveitis in Ankylosing Spondylitis: Results from the Swedish Biologics Register
  • Abstract Number: 2273
    The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study
  • Abstract Number: 1193
    The Effectiveness of Low-Impact Exercise Program on Musculoskeletal Health of Asian Older Adults
  • Abstract Number: 2360
    The Effectiveness of Tacrolimus in Patients with Interstitial Lung Disease Secondary to Autoimmune Disease
  • Abstract Number: 2923
    The Effects of Disease Activity and Mood Disorders on Cognitive Function in Systemic Lupus Erythematosus
  • Abstract Number: 2690
    The Effects of Disease of the Joints on Modified Health Assessment Questionnaire Scores in Rheumatoid Arthritis Patients: A Retrospective Study Using the National Database of Rheumatic Diseases By Ir-Net in Japan
  • Abstract Number: 1634
    The Effects of Glucocorticoids on the Efficacy of Tofacitinib As Monotherapy and in Combination Therapy with Nonbiologic Dmards: An Analysis of Data from Six Phase 3 Studies
  • Abstract Number: 3026
    The Effects of Lrg on the Differentiation of Naïve T Cells
  • Abstract Number: 368
    The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital
  • Abstract Number: 2349
    The Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients with Severe Renal Impairment
  • Abstract Number: 834
    The Efficacy of Rituximab in Systemic Sclerosis Joint Disease: A Pilot Study
  • Abstract Number: 2953
    The Emergency Room and SLE: What Characteristics Are Associated with Increased Emergency Room Utilization in Lupus Patients?
  • Abstract Number: 211
    The Epidemiology of Gout: Marked Increase in Incidence and Comorbidities over 20 Years
  • Abstract Number: 522
    The Expression of mRNA for Peptidylarginine Deiminase Type 2 and Type 4 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
  • Abstract Number: 1192
    The F-Word: Why Is Talking about Fatigue so Hard?
  • Abstract Number: 2291
    The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months
  • Abstract Number: 2442
    The Family Journey to Diagnosis with Systemic Juvenile Idiopathic Arthritis As Evidenced through Changing Social Media Presence
  • Abstract Number: 280
    The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases
  • Abstract Number: 1013
    The Fellow As Clinical Teacher Curriculum: Improving Rheumatology Fellows’ Teaching Skills during Inpatient Consultation
  • Abstract Number: 1812
    The First Randomized Control Trial to Evaluate the Effectiveness of Bortezomib for Refractory Systemic Lupus Erythematosus
  • Abstract Number: 2994
    The Global Microrna Profile of Systemic Sclerosis Whole Skin/Dermal Fibroblasts and the Role of the Xq26.3 miRNA Cluster As a TGF-b Pathway Positive Feedback Mechanism
  • Abstract Number: 2804
    The Global miRNA Whole Blood Profile of Ankylosing Spondylitis
  • Abstract Number: 3011
    The Homeoprotein Engrailed-1 Regulates Canonical TGF Beta Signaling in Experimental Systemic Sclerosis
  • Abstract Number: 1105
    The IgG/IgG4 mRNA Ratio By Quantitative PCR Accurately Diagnoses IgG4-Related Disease and Predicts Treatment Response
  • Abstract Number: 543
    The IL-20 Receptor Axis in Early Rheumatoid Arthritis: Novel Inflammation-Independent Links Between Autoantibody Positivity and Radiographic Progression
  • Abstract Number: 3152
    The IL-21 Signaling Pathway Is Enhanced in RA B Cells and Has the Potential to Alter Development and Cytokine Production in RA B Cells
  • Abstract Number: 690
    The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household
  • Abstract Number: 427
    The Impact of Biologic Agent Initiation after 1 Versus 2 Prior Csdmards in Patients with Rheumatoid Arthritis
  • Abstract Number: 3238
    The Impact of Biologic DMARD Treatment on Sepsis and Mortality after Serious Infection
  • Abstract Number: 34
    The Impact of Cardiovascular and Lung Disorder Morbidities on Physical Activity in People with Inflammatory Arthritis Compared to the General Population in the UK
  • Abstract Number: 2480
    The Impact of Emotional Trade-Off Difficulty on Choice
  • Abstract Number: 1614
    The Impact of High Risk Susceptible Gene  LILRA3  on Joint Inflammation in Rheumatoid Arthritis
  • Abstract Number: 1557
    The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis
  • Abstract Number: 1345
    The Impact of Prior Antibiotic Treatment on Culture Results of Patients with Septic Arthritis
  • Abstract Number: 2302
    The Impact of Prior Fibromyalgia Treatment on the Response to Pregabalin in Fibromyalgia Clinical Trials
  • Abstract Number: 1566
    The Impact of Severe Extra-Articular Manifestations and Patient Reported Outcome Measures on Cardiovascular Disease in Rheumatoid Arthritis
  • Abstract Number: 2939
    The Impact of Tabalumab on the Kidney in Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized Clinical Trials
  • Abstract Number: 592
    The Impact of Tobacco Smoking on the Effectiveness of Abatacept in Rheumatoid Arthritis: Data from a Paneuropean Analysis of RA Registries
  • Abstract Number: 1418
    The Importance of Comorbidity in Understanding the 6-Month Trajectories of Pain and Function after Total Hip Arthroplasty
  • Abstract Number: 3154
    The Importance of Somatic Hypermutation for the Immunoreactivity Towards Neutrophil Extracellular Traps (NETs)-Citrullinated Autoantigens of RA Synovial Monoclonal Antibodies
  • Abstract Number: 1237
    The Incidence and Prevalence of Systemic Lupus Erythematous in a Defined Population in United Arab Emirates
  • Abstract Number: 36
    The Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis: a 15 Years Observational Cohort Study
  • Abstract Number: 1951
    The Incidence Rate of Giant Cell Arteritis in Slovenia
  • Abstract Number: 4
    The Influence of Adipokines on the Interaction of Rheumatoid Arthritis Synovial Fibroblasts with Endothelial Cells
  • Abstract Number: 3262
    The Influence of Immunosuppressive Therapy on Microangiopathy in Systemic Sclerosis As Measured with Nailfoldcapillaroscopy
  • Abstract Number: 2654
    The Influence of Patient Reported Morning Stiffness on Patient Global Assessment in Rheumatoid Arthritis Patients Not Achieving ACR/EULAR Boolean Remission in a Large US Registry
  • Abstract Number: 2562
    The Inhibition of Wnt/Beta-Catenin Signaling Pathway Via Paricalcitol and Pyrvinium Ameliorates Experimental Arthritis
  • Abstract Number: 2902
    The Initial Presentation of Cerebrovascular Disease Attributed to Lupus Is Most Frequent Early in the Disease Course: Results from an International, Inception Cohort Study
  • Abstract Number: 1
    The Integrin Very Late Antigen-4 Plays a Key Role in the Recruitment of B Cells at the Inflammatory Foci
  • Abstract Number: 533
    The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity
  • Abstract Number: 762
    The Interferon Signature Correlates with Longitudinal Disease Severity in Systemic Lupus Erythematosus, but Adds Little to Conventional Prognostic Indicators
  • Abstract Number: 254
    The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in a Cohort of 13 Patients
  • Abstract Number: 2447
    The Juvenile Arthritis Disease Activity Score Remains the Disease Activity Marker of Choice for Adults with Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 3257
    The Link Between DAS28 and the Short-Term Risk of Acute Coronary Syndrome in RA, and Its Driving Factors
  • Abstract Number: 2711
    The Lung Microbiome in Rheumatoid Arthritis and Associated Local/Systemic Autoimmunity
  • Abstract Number: 768
    The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Instrument Correlates Between Trained Clinical Investigators and Clinicians
  • Abstract Number: 2469
    The Lymphocyte Repertoire in Juvenile Dermatomyositis
  • Abstract Number: 1755
    The Lymphotoxin/Megakaryoblastic Leukemia 1/Actin Axis As a Master Regulator of TLR Signaling in Lupus
  • Abstract Number: 2894
    The Majority of Patients with Moderate to Severe Psoriatic Arthritis Had Existing Structural Damage, Predisposing Them to Further Progression, Which Was Markedly Inhibited By Adalimumab
  • Abstract Number: 2609
    The Measurement of the Skin Autofluorescence As an Indicator of Disease Progression in Rheumatoid Arthritis Patients
  • Abstract Number: 1556
    The Medication Information-Seeking Behaviors of Rheumatoid Arthritis Patients Who Are Prescribed a New DMARD
  • Abstract Number: 2560
    The Mer Tyrosine Kinase Receptor Plays a Protective Role in Joint Inflammation By Mediating Efferocytosis
  • Abstract Number: 949
    The Metabolic Syndrome, Its Elements and Knee Osteoarthritis: The Framingham Osteoarthritis (OA) Study
  • Abstract Number: 2817
    The Microbiome of Reactive Arthritis in a Guatemalan Cohort
  • Abstract Number: 98
    The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Incidence Knee OA. Replication Study Including Data from Check and OAI Cohorts
  • Abstract Number: 111
    The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Radiographic OA Progression. a Meta-Analysis
  • Abstract Number: 112
    The Molecular Genetic Analysis of the Autoinflammatory Syndromes in Russian Patients with Manifestation of Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2629
    The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire
  • Abstract Number: 2601
    The Multi-Biomarker Disease Activity Score in a TNF Inhibitor Tapering Study in Rheumatoid Arthritis Patients: Predictive Value for Successful Tapering, Flaring and Radiographic Progression
  • Abstract Number: 618
    The Multi-Biomarker Disease Activity Score in Methotrexate Incomplete Responders Predicts Clinical Responses to Non-Biological Versus Biological Therapy in Early RA
  • Abstract Number: 2542
    The Multidimensional Assessment of Fatigue Scale: A 25-Year Review and Evaluation
  • Abstract Number: 907
    The Natural History of an Inception Cohort of Patients with Inflammatory Polyarthritis Followed for 20 Years: Disease Activity, Disability and Surgery
  • Abstract Number: 2907
    The Natural History of Thrombotic Events in Systemic Lupus Erythematosus and Associated Risk Factors
  • Abstract Number: 2
    The Neutrophil Protein S100A12 Has Stronger Associations with a Comprehensive Ultrasound Score of Synovitis Than Vascular Endothelial Growth Factor in a Longitudinal Study of Rheumatoid Arthritis Patients
  • Abstract Number: 6
    The Novel Role of Corticotropin-Releasing Hormone and Urocortin1 on Sjogren’s Syndrome
  • Abstract Number: 2568
    The Osteoimmunological Mechanistic Basis of Low-Dose Radiotherapy in TNF Driven Arthritis
  • Abstract Number: 1756
    The Oxidative Burst Mediates Anti-Inflammatory Clearance of Dead Cells in a Mouse Model of SLE and Inflammatory Arthritis
  • Abstract Number: 2692
    The Patients Evaluation of Pain and Disease Activity As Well As Improvement during One-Year Follow-up on Etanercept Treatment Is Highly Associated to Subjective Factors and Not to Objective Assessments Including Ultrasound
  • Abstract Number: 1291
    The Pediatric Rheumatology Workforce in 2015: A Survey of Pediatric Rheumatologists
  • Abstract Number: 1955
    The Performance of Colour-Doppler Sonography of Temporal Arteries in Patients Suspect of Having Giant Cell Arteritis in Daily Clinical Practice
  • Abstract Number: 652
    The Performance of Different Classification Criteria Sets for Spondyloarthritis in the Worldwide ASAS-Comospa Study
  • Abstract Number: 1344
    The Positive Synovial Fluid Culture:  Septic Arthritis or Contamination?
  • Abstract Number: 1079
    The Potential Effect on Recruitment of Restricting Skin Scores Eligibility Criteria in Early Diffuse Scleroderma Trials
  • Abstract Number: 2281
    The Prediction of Fatigue in Early Rheumatoid Arthritis Patients
  • Abstract Number: 651
    The Prediction of Long-Term Minimal Disease Activity and Its Benefits in Patients with Psoriatic Arthritis
  • Abstract Number: 3253
    The Predictive Value of Antibodies to Cyclic Citrullinated Peptide in Two Prospective Early Rheumatoid Arthritis Cohorts 10 Years Apart
  • Abstract Number: 1882
    The Predictive Value of Pulmonary Function Tests to Diagnose Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 256
    The Predominant Attack Type and Associated Clinical-Laboratory Conditions in Patients with Familial Mediterranean Fever
  • Abstract Number: 1691
    The Presence of Fibromialgia May Influence the Clinimetric Evaluation of Patients with Ankylosing Spondylitis, but Has No Impact on Disease Activity Assessment
  • Abstract Number: 2810
    The Presence of HLA-B27 Increases Severity of Arthritis but Does Not Appear to Influence New Bone Formation in Different in Vitro and in Vivo Models
  • Abstract Number: 1346
    The Presentation and Outcomes of Surgically Treated Septic Arthritis:  the Impact of Culture Results
  • Abstract Number: 1347
    The Presentations and Outcomes of Prosthetic Joint Septic Arthritis:  a Comparison of Culture-Positive and Culture-Negative Disease
  • Abstract Number: 740
    The Prevalence of Anti-DFS70 Antibodies in an International Inception Cohort of Systemic Lupus Erythematosus
  • Abstract Number: 237
    The Prevalence of Chondrocalcinosis of the Symphysis Pubis on CT Scan and Correlation with Calcium Pyrophosphate Dihydrate Crystal Deposition Disease
  • Abstract Number: 44
    The Prevalence of Depression and Anxiety in a Cross-Section of Rheumatological Conditions
  • Abstract Number: 1231
    The Prevalence of Non-Radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain in Rheumatology Practices
  • Abstract Number: 3120
    The Prevalence, Incidence and Management of Hypertension, Diabetes and Hyperlipidemia in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
  • Abstract Number: 2432
    The Preventive Effect of Methotrexate on Uveitis Onset in JIA Depends on Uveitis Risk Factors
  • Abstract Number: 3263
    The Promis-29 in Systemic Sclerosis: Associations with Clinical Characteristics in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort
  • Abstract Number: 1468
    The Proposed Outcome Parameters of the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC) with Uveitis Disability VAS Score Correspond Significantly with Uveitis “Classicaly Assessed” Uveitis Activity
  • Abstract Number: 1618
    The Protective Effect of HLA-DRB1*13 Alleles during Specific Phases in the Development of ACPA-Positive RA
  • Abstract Number: 1151
    The Proteomic Profile of Histological Samples Derived from a Surgical Mouse Model of Osteoarthritis Reveals an Unexpected Mode of Action for the Anti-Aggrecanase-2 Monoclonal Antibody CRB0017
  • Abstract Number: 196
    The Pyrin Domain-Only Protein POP1 Inhibits NLRP3-Dependent Inflammatory Disease
  • Abstract Number: 2408
    The Quality of Community-Based Osteoarthritis Care Can be Improved. Results from a Systematic Review and Meta-Analysis
  • Abstract Number: 3105
    The RA Immune System Recreated in Immunodeficient Mice By Thymic Differentiation from RA Patients’ Hematopoietic Stem Cells Exhibits Marked CD4 T Cell Activation and Differentiation
  • Abstract Number: 611
    The Rapid Kinetics of Optimal Treatment with Subcutaneous Methotrexate in Early Inflammatory Arthritis
  • Abstract Number: 757
    The Ratio Between TNF-a and P-Albumin – a Suggested Measure of Disease Activity in SLE
  • Abstract Number: 1739
    The Ratio of Glycated Hemoglobin A1c (HbA1c) to Glycated Albumin (GA) Is Correlated with Ankylosing Spondylitis Disease Activity Score (ASDAS) in Non-Diabetic Patients with Ankylosing Spondylitis
  • Abstract Number: 976
    The Reason of Discontinuation of a First TNF Inhibitor Affects Drug Retention of a Second Anti-TNF Agent in Axial Spondyloarthritis
  • Abstract Number: 3002
    The Regulatory Role of Gammadelta T Cells in Bleomycin-Induced Pulmonary Fibrosis
  • Abstract Number: 3251
    The Relation of Massive Weight Loss to Changes in Knee Pain and Sensitization
  • Abstract Number: 327
    The Relation of Plasma Vitamin K Status to Meniscal Pathology in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 2644
    The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis
  • Abstract Number: 552
    The Relationship Between Efficacy and Toxicity in Patients with Rheumatoid Arthritis Receiving Methotrexate in Combination with Adalimumab
  • Abstract Number: 1415
    The Relationship Between Obesity and Low Back Pain and Disability Is Affected By Mood Disorders – a Population-Based, Cross-Sectional Study of Men
  • Abstract Number: 954
    The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort
  • Abstract Number: 1381
    The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease
  • Abstract Number: 2250
    The Relationship Between Sex and Incident Knee Osteoarthritis Is Mediated By Shape
  • Abstract Number: 376
    The Relationships Between Bone Mineral Density and Radiographic Features of Hand or Knee Osteoarthritis in Older Adults: Data from the Dong-Gu Study
  • Abstract Number: 1421
    The Risk Factor of Preoperative Deep Vein Thrombosis in Patients Undergoing Total Knee Arthroplasty
  • Abstract Number: 426
    The Risk of Hospitalized Infection Following Initiation of Biologic Agents Versus Methotrexate in the Treatment of Juvenile Idiopathic Arthritis
  • Abstract Number: 1222
    The Risk of Tuberculosis (TB) in Rheumatoid Arthritis Patients Treated with TNF Inhibitors and the Safety of Resuming Biologic Dmards for Patients Who Developed TB after Anti-TNF Treatment
  • Abstract Number: 3119
    The Risk of Venous Thromboembolism in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
  • Abstract Number: 1494
    The Role of a Nurse-Led Clinic in the Assessment and Prevention of Cardio-Vascular Risk
  • Abstract Number: 239
    The Role of Dual Energy Computed Tomography in Diagnosing Acute Gouty Arthritis: Comparison with Ultrasound and Aspiration
  • Abstract Number: 2186
    The Role of Hydroxychloroquine Treatment on Pregnancy Outcome in Women with Antiphospholipid Antibodies
  • Abstract Number: 1923
    The Role of Inflammatory Myeloid Cell Compartment in Myocardial Fibrogenesis and Remodelling in Systemic Sclerosis
  • Abstract Number: 2128
    The Role of Insulin Resistance in the Development of Premature Atherosclerosis in Patients with Rheumatoid Arthritis
  • Abstract Number: 2558
    The Role of Leukocyte Associated Immunoglobulin-like Receptor-1 (LAIR-1) in Collagen-Induced Arthritis
  • Abstract Number: 2536
    The Role of Race/Ethnicity and SES in Adverse Pregnancy Outcome in SLE and Apl
  • Abstract Number: 1148
    The Role of TRPC6 in CXCR2-Mediated Chondrocyte Phenotypic Stability
  • Abstract Number: 2160
    The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis: A Diagnostic Accuracy and Cost-Effectiveness Study
  • Abstract Number: 1039
    The Safety and Effect on Disease Activity of Tocilizumab in Combination with MTX Versus Tocilizumab Monotherapy in Patients with Mild to Moderate RA: An Attempt to Optimise the Treatment Response
  • Abstract Number: 2354
    The Safety and Efficacy of Lower Serum Urate Levels: A Pooled Analysis of Gout Subjects Receiving Lesinurad and Xanthine Oxidase Inhibitors
  • Abstract Number: 3086
    The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
  • Abstract Number: 1075
    The Scleroderma Lung Study II (SLS II) Shows That Both Oral Cyclophosphamide (CYC) and Mycophenolate Mofitil (MMF) Are Efficacious in Treating Progressive Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc)
  • Abstract Number: 3074
    The Shared Rheumatoid Arthritis HLA-DRB1 Susceptibility Epitope Shapes the Molecular Orientation of Citrulline and the Autoreactive T Cell Receptor Repertoire
  • Abstract Number: 874
    The Short Term Damage Burden in Vasculitis and Vasculitis Mimics As Measured By the Vasculitis Damage Index
  • Abstract Number: 14
    The SLE Susceptibility Gene Macrophage Migration Inhibitory Factor Serves As an Upstream Regulator of NLRP3 (NOD-like receptor family pyrin domain containing 3) Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP Immune Complex
  • Abstract Number: 2081
    The SLE Workshop: An Evaluation of a Long-Standing Hospital-Based Psychoeducational Program
  • Abstract Number: 2168
    The Smoking Paradox in the Development of Myocardial Infarction Among Rheumatoid Arthritis Patients
  • Abstract Number: 3163
    The Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients
  • Abstract Number: 1205
    The Spectrum of Early RA Practice Across the Globe: Results from a Multinational Cross Sectional Survey
  • Abstract Number: 68
    The Stroop Word-Naming Test in Fibromyalgia Patients
  • Abstract Number: 2063
    The Survival Impact of Statins in Psoriasis and Psoriatic Arthritis: A General Population-Based Cohort Study
  • Abstract Number: 958
    The Time Spent in Inactive Disease before MTX Withdrawal Is Relevant with Regard to the Recurrence of Active Disease in Juvenile Idiopathic Arthritis (JIA) Patients
  • Abstract Number: 1673
    The Transcription Factor Nuclear Protein Transcriptional Regulator 1 May Contribute to Increased Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis
  • Abstract Number: 1406
    The Treatment of Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
  • Abstract Number: 2330
    The Turkish  Validity and Reliability of  the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)
  • Abstract Number: 2320
    The Use of Doppler Ultrasound in Patients with Rheumatoid Arthritis Improves Patient Understanding of Disease and Adherence to Treatment and Alters Clinical Practice
  • Abstract Number: 2915
    The Utility of Lupus Serology in Predicting Outcomes of Renal Transplantation in Lupus Patients: Systematic Review and Analysis of a Large Lupus Cohort
  • Abstract Number: 832
    The Validity and Reliability of Online Obituaries As a Source of Mortality Data
  • Abstract Number: 2539
    The Validity and Reliability of Turkish Version of the Jenkins Sleep Scale in Rheumatoid Arthritis
  • Abstract Number: 928
    The Value of Early Ultrasound-Detected Osteophytes in Hand Osteoarthritis: Predicting the Future
  • Abstract Number: 81
    The Value of Routine Use of Creatine Kinase and Thyroid Stimulating Hormone Tests in Patients with Suspected Fibromyalgia: Results of a Cross-Sectional Study
  • Abstract Number: 1060
    The View of Healthy Persons on the Impact of Spondyloarthritis on Functioning and Health: Results of a Best-Worst Scaling Based on the ASAS Health Index
  • Abstract Number: 992
    Therapeutic Targeting of CD4+ T Cell Metabolism in Murine Models of Lupus
  • Abstract Number: 1888
    There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach
  • Abstract Number: 1387
    Thoracic Paravertebral Masses and IgG4-Related Disease: Report of 8 Cases and Review of the Literature
  • Abstract Number: 1412
    Thread Carpal Tunnel Release (TCTR) Completely Divides the Transverse Carpal Ligament (TCL) As Well As Open and Endoscopic Surgery: A Cadaver Study
  • Abstract Number: 612
    Thromboembolic Events Are Not Associated with Anti-Adalimumab Antibodies
  • Abstract Number: 2013
    TIARP Attenuates Autoantibody-Mediated Arthritis Via the Suppression of Neutrophil Infiltration into the Joint
  • Abstract Number: 2215
    Ticagrelor Regulates Osteoblast and Osteoclast Function and Promotes Bone Formation in Vivo By Increasing Adenosine Levels 
  • Abstract Number: 481
    Time to Disease-Modifying Anti-Rheumatic Drug Treatment for New Patients with Rheumatoid Arthritis – Single Center Experience
  • Abstract Number: 614
    Time to First Signs of Loss of Response in Rheumatoid Arthritis Patients Treated with Anti TNF Agents: Correlations with Serum Drug Level, Immunogenicity and Csdmard Association
  • Abstract Number: 2920
    Time to Recovery of Individual Lupus Manifestations on Standard of Care Treatment
  • Abstract Number: 2372
    Timing of Onset and Cluster with Other Manifestations Influence the Spectrum of Arthritis in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International, Retrospective Study
  • Abstract Number: 586
    Titer of Anti-Citrullinated Peptide Antibody Affects the Efficacy of First Biological Treatment in Rheumatoid Arthritis
  • Abstract Number: 268
    TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still’s Disease and Their Association with Disease Activity and Clinical Manifestations
  • Abstract Number: 2012
    TNF Confers Pathogenic Memory in Synovial Fibroblasts Via Chromatin Remodeling, NF-Kb-Dependent Transcription and MAPK-Mediated mRNA Stabilization
  • Abstract Number: 444
    TNF Inhibitor Use Across Countries in Two Time Periods Using the Meteor Database
  • Abstract Number: 2581
    TNF-Alpha Receptor II Signaling Plays an Important Role in Maintaining the Expression of Forkhead Box P3 in Murine Regulatory T Cells
  • Abstract Number: 1637
    TNFi Combination Therapy, Switching and Persistence Patterns By Longitudinal Disease Activity Strata in Patients with Rheumatoid Arthritis
  • Abstract Number: 1336
    To PET or Not to PET in General Rheumatology Practice
  • Abstract Number: 285
    Tobacco Smoking in Different Racial Groups Is Differentially Associated with the Development of Myositis Autoantibodies and Interstitial Lung Disease in the Idiopathic Inflammatory Myopathies
  • Abstract Number: 265
    Tocilizumab Compared with Anakinra in Refractory Adult-Onset Still’s Disease. Multicenter Study of 75 Patients
  • Abstract Number: 3142
    Tocilizumab Enhances Regulatory T-Cell Activation and Proliferation in Giant Cell Arteritis
  • Abstract Number: 1L
    Tocilizumab for the Treatment of Giant Cell Arteritis – a Randomized Placebo-Controlled Trial
  • Abstract Number: 1487
    Tocilizumab in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Who Have Failed to Disease-Modifying Antirheumatic Drugs: Long Term Results of the Brazilian Cohort
  • Abstract Number: 1980
    Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study in France
  • Abstract Number: 1978
    Tocilizumab in Refractory Large Vessel Vasculitis with Aorta Involvement. Study on 10 Patients Evaluated By Positron Emission Tomoghraphy
  • Abstract Number: 3061
    Tocilizumab in Refractory Takayasu Arteritis. a Multicenter Study 
  • Abstract Number: 3178
    Tocilizumab in Refractory Uveitis Associated to Juvenile Idiopathic Arthritis. Multicenter Study of 13 Cases
  • Abstract Number: 3042
    Tocilizumab in Refractory Uveitis Associated with Behçet’s Disease. Multicenter Study of 7 Patients. 
  • Abstract Number: 2750
    Tocilizumab Is Effective As 1st, 2nd and 3rd-Line Biologic DMARD in Patients with Rheumatoid Arthritis
  • Abstract Number: 260
    Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever
  • Abstract Number: 1650
    Tocilizumab Monotherapy in Early Rheumatoid Arthritis: Data from Two Phase 3 Randomized Controlled Trials
  • Abstract Number: 1405
    Tocilizumab Serum Levels and Antidrug Antibodies and Its Relationship with Disease Activity in Rheumatic Diseases
  • Abstract Number: 600
    Tocilizumab Serum Trough Levels and Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 5L
    Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study
  • Abstract Number: 984
    Tofacitinib Inhibits Inflammation and New Bone Formation in Murine Spondyloarthritis but Does Not Adversely Inhibit Normal Human MSC Function
  • Abstract Number: 2801
    Tofacitinib Suppresses Lymphocytic Infiltration in the Salivary Gland of Non-Obese Diabetic Mice; The Animal Model of Sjögren’s Syndrome
  • Abstract Number: 1645
    Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
  • Abstract Number: 1834
    Total Hip Arthroplasty Outcomes: A 17 Year Experience in a Single-Center: Is Systemic Lupus Erythematosus a Real Risk Factor for Adverse Outcomes?
  • Abstract Number: 2639
    Towards Patient-Centeredness of the Treat-to-Target Paradigm: Development of a Framework for Evaluation of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance
  • Abstract Number: 1529
    Trabecular Bone Score in Early Rheumatoid Arthritis
  • Abstract Number: 351
    Trabecular Bone Score Is Severely Affected in Male Patients with Chronic Obstructive Pulmonary Disease
  • Abstract Number: 2700
    Trabecular Thinning in Metacarpophalangeal Joints of Anticitrullinated Peptide Antibody Positive Patients with Arthralgia
  • Abstract Number: 2719
    Track Along: Monocytes Follow Fibroblast-like Synoviocyte Network for Movement and Rest within the Synovial Tissue
  • Abstract Number: 1543
    Traditional Risk Score Underestimates the Cardiovascular Risk in Rheumatoid Arthritis Patients
  • Abstract Number: 2666
    Trajectories of EQ-5D in RA Patients Treated with Biologics Using the IORRA Cohort
  • Abstract Number: 1159
    Transcription Factor SOX5 Promotes Rheumatoid Arthritis Synovial Fibroblast Migration and Invasion By Regulating MMP9 Expression
  • Abstract Number: 799
    Transcriptional Profiling of Cutaneous Lupus Reveals Pronounced Changes in Keratinocyte and Myeloid Lineage Expressed Genes and Demonstrates Uniquely Regulated Interferon Pathways Between Rash Subtypes
  • Abstract Number: 2807
    Transcriptome Profiling of Synovium from Patients with Psoriatic Arthritis or Osteoarthritis Using RNA Sequencing Provides Insights into Disease Mechanisms Involved in Heterotopic Ossification with Potential Therapeutic Implications
  • Abstract Number: 1661
    Translational Data and Phase 1 Study Results of a New Monoclonal Antibody Targeting Toll like Receptor 4 (TLR4) Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine
  • Abstract Number: 1129
    Transthyretin Deposition Accelerates the Development of Experimental Osteoarthritis in Mice
  • Abstract Number: 1662
    Treat to Target of Remission Is Effective but Not All Patients Are Always in Remission
  • Abstract Number: 2878
    Treating Axial Spondyloarthritis to Target: Influence of the Population Characteristics and Comorbidities in Reaching Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Tnfalpha Inhibitors Agents
  • Abstract Number: 1167
    Treating Experimental Arthritis with Adenoviral Overexpression of IL-22 or with Blocking Antibodies Against Endogenous IL-22 Both Reduces Inflammation and Destruction
  • Abstract Number: 1364
    Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation
  • Abstract Number: 2241
    Treating to Target in Gout: The Epidemiology of Serum Urate Measurement Among Patients with Incident Gout in Usual Care Settings in the United States
  • Abstract Number: 390
    Treatment and Outcomes in Pediatric SLE Patients in South Africa
  • Abstract Number: 2341
    Treatment of Gout with Pharmacological Vs. Non-Pharmacological Complementary Therapy in the U.S.: An Internet Survey
  • Abstract Number: 2576
    Treatment of Inflammatory Arthritis with a Hybrid Compound, LLP2A-Ale, Can Prevent Joint Destruction
  • Abstract Number: 1989
    Treatment of Refractory Non-Infectious Aortitis: Tocilizumab Compared to Antitnf Alfa Agents. Multicenter Study of 44 Patients
  • Abstract Number: 3198
    Treatment of Rheumatoid Arthritis with an Anti-Tumor Necrosis Factor Agent or Tocilizumab As First Biologic Therapy in a Global Comparative Observational Study
  • Abstract Number: 497
    Treatment Outcomes in Elderly Patients with Rheumatoid Arthritis: Results from a Nationwide Korean Biologics Registry
  • Abstract Number: 2937
    Treatment Patterns Differ Based on Age of Systemic Lupus Erythematosus Onset: A Comparison of Azathioprine and Mycophenolate on the Prevention of Lupus Nephritis
  • Abstract Number: 1665
    Treatment Patterns in Rheumatoid Arthritis after Methotrexate: Data from a Rheumatoid Arthritis Cohort
  • Abstract Number: 2861
    Treatment Patterns of Subcutaneous Biologic Agent Use Among Patients with Ankylosing Spondylitis
  • Abstract Number: 429
    Treatment Preferences of Patients with Early Rheumatoid Arthritis: A Discrete-Choice Experiment
  • Abstract Number: 431
    Treatment Target in a Disease Activity Score Steered Treatment Protocol in Early Arthritis Patients: Low Disease Activity or Remission
  • Abstract Number: 2743
    Treatment Target Status at 6 Months and Long-Term Outcomes at 5 Years: Analysis of Methotrexate-Naïve Patients with Rheumatoid Arthritis
  • Abstract Number: 3205
    Treatment with Abatacept or Rituximab Targets T Follicular Helper Cells in Patients with Primary Sjogren s Syndrome
  • Abstract Number: 2150
    Treatment with Abatacept Prevents Experimental Dermal Fibrosis and Induces Regression of Established Inflammation-Driven Fibrosis
  • Abstract Number: 1784
    Treatment with Belimumab in SLE Does Not Impair Antibody Response to 13-Valent Pneumococcal Conjugate Vaccine
  • Abstract Number: 463
    Treatment with Biologic Agents for RA in Patients with MTX-Associated Lymphoproliferative Disorders
  • Abstract Number: 580
    Treatment with Biologic Agents in Rheumatoid Arthritis and Mortality Risk in Clinical Practice
  • Abstract Number: 2129
    Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Abnormalities of Vascular and Myocardial Function on Cardiac MRI
  • Abstract Number: 2768
    Trend and Factors Associated with Switching Treatment after Initial Anti-TNF Therapy Among Patients with Rheumatoid Arthritis
  • Abstract Number: 1688
    Trends in Hospitalizations and Charges for Ankylosing Spondylitis, 1993-2012
  • Abstract Number: 41
    Trends in Non-Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis: Is There Room for Improvement?
  • Abstract Number: 3269
    Trends in Prevalence of Knee Pain Among US Adults, National Health Interview Survey, 2002-2010
  • Abstract Number: 474
    Trends in the Use of Opiates in Rheumatoid Arthritis (RA) Compared to Non-RA: A Population Based Study in 2003-2012
  • Abstract Number: 1653
    Trends over Time in Achievement of Low Disease Activity Among Biologic Initiators with Rheumatoid Arthritis
  • Abstract Number: 2791
    TREX-1 Variants in Sjögren’s Syndrome Related Lymphomagenesis
  • Abstract Number: 119
    Triage in Chronic Rheumatic Diseases: Quantitative Physician Estimates for Inflammation (Reversible), Damage (Irreversible), and Distress in Patients with Rheumatoid Arthritis, Osteoarthritis, and Fibromyalgia Seen in Usual Care
  • Abstract Number: 2126
    Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Rheumatoid Arthritis
  • Abstract Number: 2201
    Triple Positivity of Antiphospholipid Antibody As the Main Thrombotic Factor in a Long-Term Follow-up Study of 98 Asymptomatic Apl-Positive Carriers
  • Abstract Number: 1824
    Tripterygium Wilfordii for the Treatment of Systemic Lupus Systematosus: Meta-Analysis of Randomized Controlled Trials
  • Abstract Number: 847
    Troponin T and NT-Probnp Are Prognostic Cardiac Disease Biomarkers in Patients with Systemic Sclerosis without Pulmonary Arterial Hypertension
  • Abstract Number: 2031
    Tuberculosis in Patients Treated with Biological Drugs
  • Abstract Number: 558
    Tuberculosis Risk Among Patients with Rheumatoid Arthritis in a United States Claims Database Initiating Abatacept and Other Biologic Disease-Modifying Antirheumatic Drugs: Analyses Using International Classification of Diseases Codes and a Published Claims Algorithm
  • Abstract Number: 2911
    Tubulointerstitial Involvement in Lupus Nephritis
  • Abstract Number: 1038
    Tumor Necrosis Factor Alpha and Peptidylarginine Deiminase 4 in Lung and Joint Inflammation
  • Abstract Number: 2842
    Tumor Necrosis Factor Alpha Inhibition in Ankylosing Spondylitis and Non Radiographic Axial Spondyloarthritis: Treatment Response, Drug Survival and Patient Outcome
  • Abstract Number: 2059
    Tumor Necrosis Factor Inhibitor Tapering Induced Radiographic Progression Is Driven By Weighted Mean Disease Activity over Time, Not Flaring or Lower TNFi Exposition
  • Abstract Number: 1023
    Tumor Necrosis Factor-a (TNF-a) and Interferon Gamma Inducible Protein-10 (IP-10) As Predictors of Active Disease Status in Localized Scleroderma
  • Abstract Number: 910
    Tumor Necrosis Factor-Alpha Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
  • Abstract Number: 1313
    Tumour Necrosis Factor Inhibitor Treatment Normalises Hand Bone Loss in a Minority of Rheumatoid Arthritis Patients Treated in Clinical Practice. Results from the Copenhagen Osteoarthritis Study and the Danbio Registry
  • Abstract Number: 382
    Twelve Months after Osteoporosis Associated Fracture – Has Adequate Therapy Been Initiated?
  • Abstract Number: 2225
    Twitter and Rheumatology: Significant and Incremental Growth in Usage
  • Abstract Number: 1197
    Two Strategies for Recruiting Rural Faith-Based Organizations for a Fall-Prevention Exercise Intervention in a Population with High Rates of Arthritis
  • Abstract Number: 2872
    Two-Year Clinical Response to Brodalumab, an Anti-Interleukin-17 Receptor Antibody, in Patients with Psoriatic Arthritis
  • Abstract Number: 1660
    Two-Year Prospective Study of Patients with Rheumatic Disease on Dose Reduction of Biological Therapy
  • Abstract Number: 2874
    Two-Years Survival of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis and Predictors Thereof in Real-Life Settings
  • Abstract Number: 3017
    TYK2 and Systemic Sclerosis Susceptibility: a New Associated Locus in the IL-12 Pathway
  • Abstract Number: 1764
    Type 1 Interferon in the Skin Stimulated By Ultraviolet B Light Generates Immune Suppression Mediated By Idoleamine 2,3-Dioxygenase 1
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology